Triple

T22452718
Position Surface form Disambiguated ID Type / Status
Subject Regulation (EC) No 141/2000 E555033 entity
Predicate officialName P66 FINISHED
Object Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products — NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products | Statement: [Regulation (EC) No 141/2000, officialName, Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products
Context triple: [Regulation (EC) No 141/2000, officialName, Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products]
  • A. Regulation (EC) No 141/2000 on orphan medicinal products chosen
    Regulation (EC) No 141/2000 on orphan medicinal products is a key European Union law that establishes incentives and a special approval framework to encourage the development and marketing of medicines for rare diseases.
  • B. Community register of orphan medicinal products
    The Community register of orphan medicinal products is the official European Union list of medicines designated for the diagnosis, prevention, or treatment of rare diseases, maintained under the EU’s orphan drug framework.
  • C. Regulation (EC) No 141/2000
    Regulation (EC) No 141/2000 is the European Union’s core legal framework establishing incentives and procedures for the designation, development, and authorization of orphan medicinal products for rare diseases.
  • D. Council Regulation (EC) No 510/2006
    Council Regulation (EC) No 510/2006 was an EU law establishing the system for protecting geographical indications and designations of origin for agricultural products and foodstuffs before being replaced by Regulation (EU) No 1151/2012.
  • E. Regulation (EC) No 726/2004
    Regulation (EC) No 726/2004 is an EU law that establishes the centralized procedure for the authorization and supervision of medicinal products and defines the role and powers of the European Medicines Agency.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e11e5113208190ab58c6b595f9d1d0 completed April 16, 2026, 5:37 p.m.
NER Named-entity recognition batch_69f15b4c63e88190aeedc326599edd18 completed April 29, 2026, 1:13 a.m.
Created at: April 16, 2026, 8:48 p.m.